| 肺鳞癌的个体化治疗进展 |
| |
| 引用本文： | 刘 欢,李高峰.肺鳞癌的个体化治疗进展[J].现代肿瘤医学,2019,0(15):2771-2775. |
| |
| 作者姓名： | 刘 欢 李高峰 |
| |
| 作者单位： | 云南省肿瘤医院/昆明医科大学第三附属医院胸外二科，云南 昆明 650118 |
| |
| 基金项目： | National Natural Science Foundation of China（No.81760554，81460356）;国家自然科学基金地区科学基金项目(编号:81760554，81460356) |
| |
| 摘 要： | 鳞状细胞肺癌(SqCLC)是非小细胞肺癌(non-small cell lung cancer，NSCLC)的一种独特的组织学亚型，尤其是晚期鳞癌，由于其特殊的临床病理特征，相对于肺腺癌可选择的治疗药物少，不良反应也大，因此肺鳞癌预后比肺腺癌差。近年来，随着化疗药物的改进，靶向药物的研发，尤其是免疫治疗的重大突破，治疗肺鳞癌有了更多的选择，肺鳞癌也走向了个体化治疗。
|
| 关 键 词： | 肺鳞癌 化疗 靶向治疗 免疫治疗 个体化治疗 |
Progress in individualized therapy of squamous cell lung cancer |
| |
| Liu Huan,Li Gaofeng.Progress in individualized therapy of squamous cell lung cancer[J].Journal of Modern Oncology,2019,0(15):2771-2775. |
| |
| Authors: | Liu Huan Li Gaofeng |
| |
| Affiliation: | Second Department of Thoracic Surgery，Tumor Hospital of Yunnan Province/Third Affiliated Hospital of Kunming Medical University，Yunnan Kunming 650118，China. |
| |
| Abstract: | Squamous cell lung cancer (SqCLC) is a unique histological subtype of non-small cell lung cancer(NSCLC)，especially advanced squamous cell carcinoma.Due to its special clinical pathological features，there are few therapeutic drugs available compared with lung adenocarcinoma，and have a large side effect，so the prognosis of squamous cell lung carcinoma is worse than lung adenocarcinoma.In recent years，with the improvement of chemotherapy drugs，the development of targeted drugs，especially the breakthrough of immunotherapy，there are more options for the treatment of lung squamous cell carcinoma，and the individualized therapy of lung squamous cell carcinoma is also on the way. |
| |
| Keywords: | squamous cell lung cancer chemotherapy targeted therapy immunotherapy individualized therapy |
|
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
|
点击此处可从《现代肿瘤医学》下载全文 |
